Boundless Bio, Inc. (BOLD) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the annual meeting of stockholders held on June 23, 2025. Boundless Bio, Inc., a Delaware corporation listed on the Nasdaq Global Select Market under the symbol BOLD, reported the voting results for two proposals submitted to its security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes and does not contain financial performance data.
Material Changes and Voting Results
The following proposals were voted upon at the annual meeting:
- Proposal 1: Election of Directors
- Christine Brennan, Ph.D.: Elected with 9,252,440 votes for, 5,046,258 votes withheld, and 3,540,518 broker non-votes.
- Nancy Whiting, Pharm.D.: Elected with 9,758,214 votes for, 4,540,484 votes withheld, and 3,540,518 broker non-votes.
- Both nominees were elected as Class I directors to serve until the 2028 annual meeting.
- Proposal 2: Ratification of Independent Auditor
- Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Votes For: 17,791,309
- Votes Against: 47,807
- Abstentions: 100
- Broker Non-Votes: 0
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on outlook, specific risks, contingencies, or unusual items. Detailed descriptions of the proposals were referenced as being available in the definitive proxy statement filed on April 29, 2025.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to calculate the percentage of votes for and against each proposal.
- Review the definitive proxy statement filed on April 29, 2025, for detailed biographies of the elected directors and the rationale for the auditor ratification.
- Confirm the specific terms of the Class I director tenure ending in 2028.
- Note the significant number of broker non-votes (3,540,518) on the director election, indicating shares held by brokers that were not voted due to lack of instructions.